Tilray (TLRY) appoints former Goldman Sachs Managing Director to Chief Corporate Development Officer

: TLRY | Tilray, Inc. - Class 2 Common Stock News, Ratings, and Charts

TLRY – In his new role, Pucher will be responsible for Tilray’s corporate development and will also manage the team responsible for M&A and corporate investments.

Tilray Inc. TLRY 0.52% on Wednesday announced the expansion of its global senior leadership team. The company appointed Andrew Pucher, a former managing director atGoldman Sachs Group Inc GS 0.15%, as its new Chief Corporate Development Officer.

In his new role, Pucher will be responsible for Tilray’s corporate development and will also manage the team responsible for M&A and corporate investments.

Pucher served as Head of Canadian Diversified Investment Banking at Goldman, where he also covered the country’s cannabis industry. Prior to that, he was a member of Goldman’s Global Healthcare Investment Banking Group, where he advised on over $200 billion in announced M&A and financing transactions, mostly in the biopharmaceutical industry.

Why It’s Important

The appointment follows a string of hires from other industries:

  • In January, Greg Christopher joined Tilray from Nestle as EVP of Operations;
  • Rita Seguin from Diageo became Tilray’s EVP of Human Resources;
  • General Counsel Dara Redler previously worked at Coca-Cola; and
  • Charlie Cain, formerly of Starbucks, was appointed VP of Retail.

The appointment comes after Tilray signed a number of deals and partnerships expanding its reach and international presence.

The company and its subsidiaries formed a partnership with Novartis AG NVS 0.64%‘s Sandoz division to distribute medical products, created a 50/50 joint venture with Anheuser Busch Inbev NV BUD 1.2%‘s Labatt to develop THC and CBD-infused beverages, signed an agreement to produce CBD products for Authentic Brands Group. Most recently, Tilray announced the acquisition of Manitoba Harvest, the largest manufacturer of hemp food products.


Tilray Inc. shares were trading at $72.09 per share on Thursday afternoon, up $0.29 (+0.40%). Year-to-date, TLRY has gained 2.20%, versus a 12.49% rise in the benchmark S&P 500 index during the same period.

TLRY currently has a StockNews.com POWR Rating of NR (Not Rated), and is ranked # of 201 stocks in the Medical – Pharmaceuticals category.


This article is brought to you courtesy of Benzinga.

9 "Must Own" Growth Stocks For 2019

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: DIS | Walt Disney Company (The) Common Stock News, Ratings, and Charts

Disney's (DIS) new live-action film, Aladdin, expected to make $80 million this weekend

The live-action “Aladdin” film starring Will Smith is expected to lead the box office over the Memorial Day holiday weekend.
NYSE: SQ | Square, Inc. Class A Common Stock News, Ratings, and Charts

Is Square (SQ) stock a good buy at this price level?

SQ stock now trades for just $65.
NYSE: F | Ford Motor Company Common Stock News, Ratings, and Charts

Is it possible Ford (F) would buy Tesla (TSLA)

Making a deal work would be a challenge.
NASDAQ: CVCO | Cavco Industries, Inc. News, Ratings, and Charts

Best & Worst Performing Stock Industries for May 24, 2019

Led by ticker CVCO, "Homebuilders" was our best performing stock industry of the day, with a 2.60% gain.
NYSE: EMES | Emerge Energy Services LP Common Units representing Limited Partner Interests News, Ratings, and Charts

Best & Worst Performing Small Cap Stocks for May 24, 2019

EMES leads the way today as the best performing small cap stock, closing up 76.47%.

Read More Stories


More Tilray, Inc. - Class 2 Common Stock (TLRY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TLRY News
Page generated in 1.1654 seconds.